Prescription drug prices are once again a key focus in Washington, with policymakers on both sides of the aisle looking for solutions to improve affordability and access. Some have suggested pegging reimbursement to prices paid in other countries. Critics say this is tantamount to price controls while supporters call it a fair measure to rein in rising costs.
Join CAHC and our panel of expert guests on Wednesday, April 17th at noon in SD-G11 as we separate fact from fiction with a briefing entitled, “The ABCs of Medicare Part B: Affordability Challenges for Physician-Administered Drugs & Proposals for Reform.”
Lunch will be served! Save your spot and RSVP today.
See you on the 17th!